← FDA Drug Approvals (Drugs@FDA)
ZYCUBO
NDA · New Drug Application · Sponsor: SENTYNL THERAPS INC · Approved 2026-01-12
Drug application
- FDA Application #
NDA211241- Application type
- New Drug Application
- Brand name
- ZYCUBO
- Generic name
- COPPER HISTIDINATE
- Active ingredients
- COPPER HISTIDINATE
- Dosage form
- POWDER
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- SENTYNL THERAPS INC
- Manufacturer
- Sentynl Therapeutics, Inc.
- First approval
- 2026-01-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown